Literature DB >> 6307136

Antimicrobial activity of cefmenoxime compared with those of other cephalosporins.

R F Schell, B R Smith, J L LeFrock, M A Francisco.   

Abstract

The antimicrobial activity of cefmenoxime was compared with those of cefamandole, cefoperazone, cefotaxime, cephalothin, and moxalactam. In general, the activity of cefmenoxime was equivalent to those of the other cephalosporins. Cefmenoxime appears to be a potent antimicrobial agent against most gram-negative microorganisms other than Pseudomonas aeruginosa and Acinetobacter spp.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6307136      PMCID: PMC184814          DOI: 10.1128/AAC.23.5.774

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  5 in total

1.  Comparative in vitro activities of cefmenoxime (SCE-1365) and newer cephalosporin derivatives of clinical utility.

Authors:  V I Ahonkhai; C E Cherubin; M A Shulman; U Bancroft
Journal:  Antimicrob Agents Chemother       Date:  1982-06       Impact factor: 5.191

2.  Cefmenoxime (SCE-1365), a new cephalosporin: in vitro activity, comparison with other antimicrobial agents, beta-lactamase stability, and disk diffusion testing with tentative interpretive criteria.

Authors:  P C Fuchs; R N Jones; C Thornsberry; A L Barry; E H Gerlach; H M Sommers
Journal:  Antimicrob Agents Chemother       Date:  1981-12       Impact factor: 5.191

3.  Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.

Authors:  K Tsuchiya; M Kondo; M Kida; M Nakao; T Iwahi; T Nishi; Y Noji; M Takeuchi; Y Nozaki
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

4.  In vitro activity and beta-lactamase stability of cefmenoxime.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

5.  Antimicrobial activity of cefmenoxime (SCE-1365).

Authors:  J M Stamm; R L Girolami; N L Shipkowitz; R R Bower
Journal:  Antimicrob Agents Chemother       Date:  1981-03       Impact factor: 5.191

  5 in total
  7 in total

Review 1.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

2.  Susceptibilities of 45 clinical isolates of Proteus penneri.

Authors:  M Fuksa; S Krajden; A Lee
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

Review 3.  Cephalosporins in surgery. Prophylaxis and therapy.

Authors:  D W McEniry; S L Gorbach
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Efficacy of cefmenoxime in experimental Escherichia coli bacteremia and meningitis.

Authors:  K S Kim
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

Review 5.  Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

6.  Clinical efficacy and safety of cefmenoxime in children.

Authors:  G F Tansino; M R Hammerschlag; B L Congeni; P A Cox; B Doraiswamy; L duBouchet
Journal:  Antimicrob Agents Chemother       Date:  1985-10       Impact factor: 5.191

7.  Antimicrobial activities of BMY-28142, cefbuperazone, and cefpiramide compared with those of other cephalosporins.

Authors:  N J Khan; J A Bihl; R F Schell; J L LeFrock; S J Weber
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.